In ARDS patients, we observed that PON1 activity (standardized to HDL-C level) was almost two-fold lower than in non-ARDS patients (7.9±2.3 vs. 14.5±3.6, NS). The gene discussed is PON1; the disease is acute respiratory distress syndrome.